Peanut Allergy Clinical Trial Pipeline: Insights into a Growing Landscape with 12+ Companies Advancing Novel Treatments| DelveInsight [Yahoo! Finance]
DBV Technologies S.A. - American Depositary Shares (DBVT)
US:NASDAQ Investor Relations:
dbv-technologies.com/en/investor-relations
Company Research
Source: Yahoo! Finance
This heightened awareness among families, schools, and healthcare providers is driving demand for proactive treatments beyond simple avoidance. As a result, the market is witnessing the emergence of innovative therapies like oral immunotherapy, peptides, and mucosal delivery systems aimed at inducing lasting immune tolerance. New York, USA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Peanut Allergy Clinical Trial Pipeline: Insights into a Growing Landscape with 12+ Companies Advancing Novel Treatments| DelveInsight Peanut allergy is a growing health concern, especially in children, with rising incidence and increased public awareness of its severity and risks. This heightened awareness among families, schools, and healthcare providers is driving demand for proactive treatments beyond simple avoidance. As a result, the market is witnessing the emergence of innovative therapies like oral immunotherapy, peptides, and mucosal delivery systems aimed at inducing lasting immune tolerance. Delve
Show less
Read more
Impact Snapshot
Event Time:
DBVT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DBVT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DBVT alerts
High impacting DBV Technologies S.A. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
DBVT
News
- DBV Technologies (NASDAQ:DBVT) was upgraded by analysts at Guggenheim to a "strong-buy" rating. They now have a $35.00 price target on the stock.MarketBeat
- DBV Technologies (NASDAQ:DBVT) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock.MarketBeat
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025GlobeNewswire
- DBV Technologies (NASDAQ:DBVT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- DBV Technologies (NASDAQ:DBVT) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
DBVT
Sec Filings
- 11/25/25 - Form 4
- 11/24/25 - Form 4
- 11/24/25 - Form 4
- DBVT's page on the SEC website